Welcome to our dedicated page for Modivcare SEC filings (Ticker: MODV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
ModivCare Inc. filings document the formal record for a healthcare services issuer undergoing Chapter 11 proceedings and a completed Nasdaq delisting. Recent 8-K and Form 25 disclosures address listing-rule notices, suspension of the common stock from The Nasdaq Global Select Market, quotation on the OTC Markets Expert Market under MODVQ, and removal of the common stock from Nasdaq listing and Section 12(b) registration.
The company’s SEC record also includes late-filing notifications for quarterly reports, material-event disclosures, governance changes such as director departures, and capital-structure and shareholder-voting matters. These filings frame the company’s supportive care operations, reporting status, exchange status and restructuring-related disclosure obligations.
ModivCare Inc. announced that director David Mounts Gonzales resigned from its Board, effective November 9, 2025. The company stated his departure was not due to any disagreement regarding operations, policies, or practices.
As trading context, at the opening of business on August 28, 2025, the company’s common stock was suspended from Nasdaq and began being quoted on the Expert Market operated by OTC Markets Group under the symbol MODVQ. Nasdaq filed a Form 25‑NSE on October 1, 2025 to delist the common stock and remove it from registration under Section 12(b).
ModivCare Inc. filed a Form 12b-25 (NT 10-Q) for the quarter ended September 30, 2025, notifying a late filing. The company needs more time to complete its ongoing goodwill impairment assessment, to evaluate results of an investigation conducted by outside counsel at the Audit Committee’s direction, and to finalize documentation and reviews amid competing demands tied to its previously disclosed Chapter 11 bankruptcy.
ModivCare anticipates that consolidated revenue and net income (loss) for the quarter ended September 30, 2025 will be significantly lower than the comparable period last year, due in part to reorganization expenses and professional fees approved by the Bankruptcy Court in connection with its Chapter 11 Cases. The company also noted it has not filed its Form 10‑Q for the quarter ended June 30, 2025.
ModivCare Inc (MODV) is the subject of a Form 25 notice filed with the SEC to remove its class of securities from listing and/or registration on the Nasdaq Stock Market LLC. The filing lists the issuer's principal office at 5524 E. Fourth Street, Tucson, AZ 85711 and a contact phone 520-748-7108. The document cites compliance with the Exchange and SEC procedures for removal but does not state which specific rule box was selected or give a removal date.
ModivCare Inc. disclosed it commenced voluntary Chapter 11 bankruptcy proceedings on August 20, 2025 and received Nasdaq notices that it is no longer suitable for listing and is delinquent in regulatory filings. Nasdaq determined to commence delisting proceedings and informed the company the common stock would be suspended at the opening of business on August 28, 2025. The company does not intend to appeal and expects Nasdaq to file to remove the listing, after which the stock may quote on the OTC Pink market, though that is not assured.
ModivCare Inc. (MODV) commenced voluntary Chapter 11 cases on August 20, 2025, and entered a Restructuring Support Agreement with consenting first‑lien lenders and second‑lien noteholders to implement a court‑supervised recapitalization. The RSA contemplates $100 million of debtor‑in‑possession (DIP) financing, up to $300 million of takeback term loans at emergence, conversion of approximately $871 million of first‑lien claims into $200 million of exit debt plus ~98% pro forma equity, and conversion of ~ $316 million of second‑lien claims into ~2% pro forma equity. The plan also contemplates new warrants, a potential $200 million equity rights offering, and a $250 million revolving facility. The restructuring would reduce funded debt by about $1.1 billion. The company continues as debtor‑in‑possession, has requested customary "first day" relief, and cautions that common stockholders may suffer significant or complete loss.
ModivCare Inc. notified the SEC that it cannot timely file its Quarterly Report for the quarter ended June 30, 2025 because it needs more time to complete a goodwill impairment assessment and to finish an outside-counsel investigation, directed by the Audit Committee, into compliance hotline allegations including matters related to the company’s culture. The company says these matters are material to its consolidated interim financial statements.
ModivCare also warns that consolidated revenue, EBITDA and Adjusted EBITDA for the quarter are expected to be significantly lower versus the prior-year period, driven in part by an expected goodwill impairment of not less than $250 million, which could be larger as the assessment continues.